Levodopa is associated with reduced development of neovascular age-related macular degeneration.

[1]  David F Williams,et al.  Longer Term Visual Outcomes in Neovascular AMD, Diabetic and Vein Occlusion Related Macular Edema: Clinical Outcomes in 130,247 Eyes. , 2022, Ophthalmology. Retina.

[2]  Adam P. DeLuca,et al.  Spectacle: An interactive resource for ocular single-cell RNA sequencing data analysis. , 2020, Experimental eye research.

[3]  B. McKay,et al.  Levodopa Positively Affects Neovascular Age-Related Macular Degeneration , 2020, The American journal of medicine.

[4]  B. McKay,et al.  A G-Protein Coupled Receptor and Macular Degeneration , 2020, Cells.

[5]  R. Avery,et al.  Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients With Age-Related Macular Degeneration Treated With Intravitreal Aflibercept or Ranibizumab. , 2019, JAMA ophthalmology.

[6]  B. Yaspan,et al.  Imaging, Genetic, and Demographic Factors Associated With Conversion to Neovascular Age-Related Macular Degeneration: Secondary Analysis of a Randomized Clinical Trial. , 2019, JAMA ophthalmology.

[7]  Darius M Moshfeghi,et al.  Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration , 2015, The American journal of medicine.

[8]  W. Stamer,et al.  Controlled exosome release from the retinal pigment epithelium in situ. , 2014, Experimental eye research.

[9]  R. Avery,et al.  Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials. , 2013, Ophthalmology.

[10]  Cynthia A. Toth,et al.  Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. , 2013, JAMA.

[11]  S. Sherman,et al.  PEDF and VEGF-A Output from Human Retinal Pigment Epithelial Cells Grown on Novel Microcarriers , 2012, Journal of biomedicine & biotechnology.

[12]  C. Decatur,et al.  L-DOPA Is an Endogenous Ligand for OA1 , 2008, PLoS biology.

[13]  C. Tanner,et al.  Levodopa and the progression of Parkinson's disease. , 2004, The New England journal of medicine.

[14]  T. Tsuruo,et al.  The 4F2hc/LAT1 complex transports l-DOPA across the blood–brain barrier , 2000, Brain Research.

[15]  J. Weiter,et al.  Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. , 1986, Investigative ophthalmology & visual science.

[16]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.